OSTX - OS Therapies Inc
1.57
0.060 3.822%
Share volume: 543,990
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.26%
PREVIOUS CLOSE
CHG
CHG%
$1.51
0.06
0.04%
View ratios
| Fiscal Date | 09-30-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|
| Fiscal Quarter | Q3 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 11-15-2024 | 05-15-2025 | 11-14-2025 | |
| Cash flow financing | 5.148 M | 1.053 M | 3.781 M | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | |
| Cash flow | 0.000 | -2.563 M | 0.000 | |
| Net income | -2.875 M | -3.877 M | -6.880 M | |
| Depreciation | 0.000 | 695.000 | 124.938 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 0.000 | -173.636 K | 0.000 | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | -150.000 K | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 0.000 | |
| Cash Change | 1.763 M | -3.131 M | -925.387 K |